Information Provided By:
Fly News Breaks for May 1, 2015
DRRX
May 1, 2015 | 07:02 EDT
Cantor raised its price target on DURECT after the company reported in-line Q1 revenue and higher than expected EPS. The firm added cash from two potential Relday-associated milestones to its 2016 and 2017 collaborative R&D revenue estimates. Cantor says the company has multiple upcoming catalysts, and it keeps a Buy rating on the shares.
News For DRRX From the Last 2 Days
There are no results for your query DRRX